Genedata Biopharma Platformは、高度な解析とAI駆動の科学的洞察で研究開発ワークフローの自動化とイノベーションの推進を実現する、業界初のエンタープライズソフトウェアプラットフォームです。より良い治療法をより迅速かつ高いコスト効率で届けるために尽力するバイオファーマ企業をサポートします。
All Therapeutic Modalities. Supported.
A central end-to-end digital backbone enables the registration and tracking of both complex biologics and small molecules, integrating analytics and functional assay results into a ‘single source of truth’ across R&D.
Small Molecules
Antibodies,
Enzymes
Next Generation Molecules:
Bi- & Multi-specifics, ADCs…
Cell & Gene Therapies:
CAR Ts, TCR-Ts, iNKs, Lentivirus, AAV…
RNA Therapies & Vaccines:
Oligonucleotides, mRNA-LNP…
Eight Systems. Working Separately or Together.
The Genedata Biopharma Platform is composed of eight systems that can be used together or individually to enable innovation, accelerate R&D workflows, increase R&D efficiency and ultimately improve clinical success.
Discover the Platform
- BIOLOGICS - Biotherapeutics Discovery
- BIOPROCESS - Bioprocess Development
- CHROMATICS - Chromatography Workflows
- EXPRESSIONIST - Mass Spectrometry Data Analysis
- PROFILER - Precision Medicine
- SCREENER - Assay Analytics & Management
- SELECTOR - NGS-Based Development & Biosafety
- VICO - Digital CMC
Increase Bioengineering Output by 10 x
Software Benefits:
- Register all biotherapeutic modalities
- Streamline screening and optimization processes and biological data handling
- Automate data capture and analysis from instruments and robotics
- Drive innovation with a structured data foundation for AI/ML
- Ensure data integrity & traceability
Increase Process Development Efficiency by 200%
Software Benefits:
- Connect bioprocess development end to end
- Ensure regulatory compliance
- Support quality by design (QbD)
- Automate and streamline processes
- Reduce manual efforts with instrument integration
- Introduce digital twins/modeling
Cut Chromatography Data Analysis Time by over 15 x
Software benefits:
- Streamline analysis and reporting of all chromatography data
- Automate and harmonize, and connect workflows for peak quantification and analysis
- Create high quality, FAIR protein purification and developability data
- Enable data sharing across R&D teams and fosters AI-readiness
Eliminate 90% of Manual Data Processing Time
Software Benefits:
- Streamline mass spectrometry workflows
- Perform In-depth molecular characterization
- Automate and customize data processes
- Support multi-attribute method (MAM) implementations
- Assess product quality in a GXP compliant environment
Improve Clinical Trial Success Rate by 20%
Software Benefits:
- Identify new therapies
- Define new therapeutic indications
- Discover/validate novel biomarkers
- Leverage real world data
- Design smarter, targeted clinical trials
- Enable precision medicine
Reduce Assay Analysis Time from 3 Days to 3 Hours
Software Benefits:
- Harmonize all plate-based assays and analyses on a single platform
- Get structured data and standardized metadata for FAIR, AI-ready datasets
- Automate assay analysis from reader to report
- Employ cutting-edge assay technologies, including multiplexed and label-free
- Perform deep, scientifically-appropriate analysis using smart fitting and model selection
- Automate routine analyses with AI/ML-based methods
Reduce Product Characterization Time by 90%
Software Benefits:
- Automate NGS-based workflows
- Use proprietary genome annotation
- Support CRISPR-based target engineering
- Develop stable cell lines
- Critical quality attributes (CQA) & MAM assessment
- Optimize bioprocessing with omics data
- Perform biosafety testing in a GMP compliant environment
Reduce CMC-Driven Regulatory Risk and Costly Delays
Software benefits:
- Enhance prediction and process understanding
- Generate GxP-compliant AI outcomes
- Anticipate risk and enable real-time process control
- Detect deviations early through closed-loop learning and AI-augmented PAT
- Answer CMC questions with purpose-built agentic AI
- Strengthen tech transfer and drug lifecycle management
Trusted by World-Leading Companies
The Genedata platform is the core knowledge management system for our global Biologics Engineering organization, helping us to streamline our research with the aim of developing novel therapies, faster.
Simon Chell, Ph.D.
Vice President of Biologics Engineering
Genedata Biologics was the obvious choice because it is a proven, off-the-shelf enterprise platform that can be rapidly deployed across our organization.
Unlock Synergies Across Groups & Workflows. Drive Automation and AI.
Accelerating time-to-IND
Learn how Novartis, a leading global biopharmaceutical company, accelerates time-to-IND by transforming how it manages, integrates, and analyzes CMC data.
Data Backbone Connects R&D Organization
“Now that we have a central data backbone in place where all information can be accessed and shared, our R&D groups can spend their time on critical scientific tasks, instead of manual data reporting and management.”